Repurposing Nano Curcumin: Unveiling its Therapeutic Potential in Diabetic Nephropathy

Area of Science:

• Nephrology
• Pharmacology
• Oxidative Stress Research

Background:

• Diabetic nephropathy (DN) is a leading cause of end-stage renal disease, driven by hyperglycemia-induced vascular dysfunction, fibrosis, inflammation, and oxidative stress.
• Current therapies primarily target hypertension and glucose control, necessitating novel therapeutic strategies.
• Curcumin, a natural antioxidant, is increasingly recognized for its anti-inflammatory and antioxidant properties relevant to DN.

Purpose of the Study:

• To review the therapeutic role of curcumin in diabetic nephropathy (DN).
• To elucidate curcumin's mechanisms of action, focusing on its impact on oxidative stress and inflammation.
• To explore the bench-to-bedside applications of curcumin in DN, integrating preclinical and clinical evidence.

Main Methods:

• Literature review of preclinical and clinical studies on curcumin in diabetic nephropathy.
• Analysis of curcumin's molecular targets, including Nrf2, SIRT1, HMGB1, NF-κB, and NLRP3.
• Synthesis of evidence regarding curcumin's anti-inflammatory and antioxidant effects in the context of DN.

Main Results:

• Curcumin exhibits significant anti-inflammatory and antioxidant characteristics.
• Curcumin modulates key pathways (Nrf2, SIRT1, HMGB1, NF-κB, NLRP3) involved in DN pathogenesis.
• Evidence suggests curcumin can alleviate DN symptoms and damage in kidney cells.

Conclusions:

• Curcumin demonstrates considerable therapeutic potential for diabetic nephropathy.
• Its ability to target oxidative stress and inflammation makes it a promising agent for DN treatment.
• Further clinical investigation supports curcumin's role as a viable therapeutic option for patients with DN.